First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient.
published in: Journal of Immunotherapy
date of publication: 2017-10-01
main subject: synovial sarcoma, metastatic synovial sarcoma, dendritic cell
Cites articles 13
Date
Title
Article - wd:Q50160827